Literature DB >> 8478070

Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase.

A Habara-Ohkubo1, T Shirahata, O Takikawa, R Yoshida.   

Abstract

Indoleamine 2,3-dioxygenase (IDO), a tryptophan-degrading enzyme, is inducible by various interferons (IFNs). IDO-mediated tryptophan degradation, but not the formation of IDO-catalyzed tryptophan metabolites, has been suggested as a mechanism for the antiparasitic action of IFN-gamma. To determine whether the IFN-gamma-induced IDO alone is sufficient for establishing the antiparasitic state, we constructed a mouse IDO expression plasmid containing a heavy metal-responsive metallothionein promoter and obtained a stable transformant (C6) by transfection of this plasmid into mouse rectal cancer (CMT-93) cells. In the presence of 100 microM ZnSO4, C6 cells yielded a high level of IDO; and after a 2-day culture period, the enzyme induction resulted in complete depletion of tryptophan from the culture medium. Under these conditions, the growth of Toxoplasma gondii in C6 cells infected with the organisms on day 3 after enzyme induction was completely blocked. In the absence of ZnSO4, however, IDO induction was negligible in C6 cells, and T. gondii continued to grow. Furthermore, in a transformant (CC10) carrying an antisense mouse IDO plasmid or in parental CMT-93 cells, IDO was not induced at all even in the presence of 100 microM ZnSO4, and T. gondii continued to grow in these cells as well. These results taken together indicate that complete depletion of tryptophan from the culture by IDO alone is sufficient to establish the antitoxoplasma state in mouse cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478070      PMCID: PMC280769          DOI: 10.1128/iai.61.5.1810-1813.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Specific labeling of intracellular Toxoplasma gondii with uracil.

Authors:  E R Pfefferkorn; L C Pfefferkorn
Journal:  J Protozool       Date:  1977-08

3.  Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.

Authors:  G I Byrne; L K Lehmann; G J Landry
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Growth inhibition of Toxoplasma gondii in cell cultures treated with murine type II interferon.

Authors:  T Shirahata; K Shimizu
Journal:  Nihon Juigaku Zasshi       Date:  1982-12

5.  Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

Authors:  E R Pfefferkorn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

6.  Constitutive production of human interferons by mouse cells with bovine papillomavirus as a vector.

Authors:  R Fukunaga; Y Sokawa; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.

Authors:  O Takikawa; R Yoshida; R Kido; O Hayaishi
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

8.  A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons.

Authors:  J Weil; C J Epstein; L B Epstein; J J Sedmak; J L Sabran; S E Grossberg
Journal:  Nature       Date:  1983-02-03       Impact factor: 49.962

9.  Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene.

Authors:  M Karin; R I Richards
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  6 in total

1.  L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.

Authors:  Suwako Fujigaki; Kuniaki Saito; Masao Takemura; Naoya Maekawa; Yasuhiro Yamada; Hisayasu Wada; Mitsuru Seishima
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon.

Authors:  Karola Obojes; Oliver Andres; Kwang Sik Kim; Walter Däubener; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 3.  Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.

Authors:  Burles A Johnson; Babak Baban; Andrew L Mellor
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

4.  Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts.

Authors:  S L Gupta; J M Carlin; P Pyati; W Dai; E R Pfefferkorn; M J Murphy
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G S Yap; A Sher
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

Review 6.  Impact of the host on Toxoplasma stage differentiation.

Authors:  Carsten G K Lüder; Taibur Rahman
Journal:  Microb Cell       Date:  2017-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.